Local Delivery and Glioblastoma: Why Not Combining Sustained Release and Targeting?
Gliadel® wafers
glioblastoma
local delivery
nanoparticle-loaded hydrogel
targeting
Journal
Frontiers in medical technology
ISSN: 2673-3129
Titre abrégé: Front Med Technol
Pays: Switzerland
ID NLM: 101772626
Informations de publication
Date de publication:
2021
2021
Historique:
received:
08
10
2021
accepted:
28
10
2021
entrez:
20
1
2022
pubmed:
21
1
2022
medline:
21
1
2022
Statut:
epublish
Résumé
Glioblastoma is one of the most aggressive brain tumors and is associated with a very low overall median survival despite the current treatment. The standard of care used in clinic is the Stupp's protocol which consists of a maximal resection of the tumor when possible, followed by radio and chemotherapy using temozolomide. However, in most cases, glioblastoma cells infiltrate healthy tissues and lead to fatal recurrences. There are a lot of hurdles to overcome in the development of new therapeutic strategies such as tumor heterogeneity, cell infiltration, alkylating agent resistance, physiological barriers, etc., and few treatments are on the market today. One of them is particularly appealing because it is a local therapy, which does not bring additional invasiveness since tumor resection is included in the gold standard treatment. They are implants: the Gliadel
Identifiants
pubmed: 35047971
doi: 10.3389/fmedt.2021.791596
pmc: PMC8757870
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
791596Informations de copyright
Copyright © 2021 Gazaille, Sicot, Saulnier, Eyer and Bastiat.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Neurosurgery. 1997 Jul;41(1):44-8; discussion 48-9
pubmed: 9218294
J Pathol. 2008 Sep;216(1):15-24
pubmed: 18553315
Eur Neurol. 2017;77(3-4):201-210
pubmed: 28192785
Cancer Res. 1992 Oct 1;52(19):5334-41
pubmed: 1382841
Oncologist. 2009 Nov;14(11):1131-8
pubmed: 19897538
Lancet Oncol. 2006 May;7(5):392-401
pubmed: 16648043
Int J Nanomedicine. 2014 Nov 13;9:5261-71
pubmed: 25419130
J Pathol. 2003 Jul;200(4):423-8
pubmed: 12845610
Small. 2016 Aug;12(31):4241-53
pubmed: 27356892
World J Surg Oncol. 2016 Aug 24;14(1):225
pubmed: 27557526
Neoplasia. 2015 Apr;17(4):374-84
pubmed: 25925380
J Control Release. 2020 Mar 10;319:311-321
pubmed: 31911154
Nat Rev Clin Oncol. 2018 Jul;15(7):422-442
pubmed: 29643471
Brain Tumor Pathol. 2016 Apr;33(2):97-106
pubmed: 26992378
Biomaterials. 2013 Jul;34(22):5640-50
pubmed: 23639530
J Control Release. 2016 Mar 10;225:283-93
pubmed: 26829100
Soft Matter. 2014 Mar 21;10(11):1767-77
pubmed: 24652455
Cancer Res. 1993 Jan 15;53(2):329-33
pubmed: 8417826
J Control Release. 2016 Apr 10;227:23-37
pubmed: 26892752
Drug Des Devel Ther. 2015 Jun 29;9:3341-8
pubmed: 26170620
J Cell Sci. 2002 Oct 15;115(Pt 20):3861-3
pubmed: 12244123
J Mater Chem B. 2019 Oct 9;7(39):5896-5919
pubmed: 31423502
JAMA. 1979 Mar 9;241(10):1016-8
pubmed: 216819
Mol Pharm. 2014 Jan 6;11(1):90-101
pubmed: 24295590
J Neurooncol. 2018 Jun;138(2):241-250
pubmed: 29453678
Eur J Pharm Biopharm. 2000 Jul;50(1):27-46
pubmed: 10840191
Oncotarget. 2016 Jun 7;7(23):34158-71
pubmed: 27120809
ACS Nano. 2015 Feb 24;9(2):1581-91
pubmed: 25558928
Expert Rev Anticancer Ther. 2013 Dec;13(12):1453-61
pubmed: 24236823
Cell. 2010 Jun 25;141(7):1117-34
pubmed: 20602996
ACS Appl Mater Interfaces. 2015 Apr 1;7(12):6674-82
pubmed: 25751368
Genes Cancer. 2011 Aug;2(8):771-81
pubmed: 22393462
Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23714-23723
pubmed: 31712430
Cancer Res. 2003 Sep 15;63(18):5821-8
pubmed: 14522905
ACS Appl Mater Interfaces. 2014 Aug 27;6(16):13738-48
pubmed: 25073123
J Biomater Sci Polym Ed. 2013;24(9):1112-26
pubmed: 23683041
Cold Spring Harb Perspect Biol. 2014 Apr 01;6(4):a020768
pubmed: 24691965
Nat Cell Biol. 2015 Feb;17(2):170-82
pubmed: 25580734
Nat Rev Immunol. 2009 Mar;9(3):162-74
pubmed: 19197294
Neuro Oncol. 2020 Oct 30;22(12 Suppl 2):iv1-iv96
pubmed: 33123732
Acta Biomater. 2017 Aug;58:12-25
pubmed: 28576716
Sci Rep. 2020 Apr 2;10(1):5809
pubmed: 32242067
Mol Cancer Res. 2012 Jul;10(7):958-68
pubmed: 22571869
ACS Appl Mater Interfaces. 2016 Mar 23;8(11):6811-25
pubmed: 26911360
J Control Release. 2019 Aug 28;308:109-118
pubmed: 31255690
Mol Pharm. 2015 Sep 8;12(9):3250-60
pubmed: 26198693
Biomater Sci. 2018 May 1;6(5):1140-1146
pubmed: 29557480
Bioact Mater. 2020 May 07;5(3):624-635
pubmed: 32405577
ACS Nano. 2014 Oct 28;8(10):10383-95
pubmed: 25247850
Biomaterials. 2015 Feb;42:42-51
pubmed: 25542792
J Neurooncol. 2019 Feb;141(3):479-486
pubmed: 30644008
Biomed Pharmacother. 2016 Feb;77:98-107
pubmed: 26796272
Molecules. 2015 Nov 13;20(11):20397-408
pubmed: 26580588
Mol Med Today. 1995 Jun;1(3):134-9
pubmed: 9415149
Oncotarget. 2016 Jul 12;7(28):43095-43108
pubmed: 27191269
Neoplasma. 2008;55(5):369-74
pubmed: 18665745
Nature. 2004 Nov 18;432(7015):396-401
pubmed: 15549107
Pathol Int. 2012 Jul;62(7):463-70
pubmed: 22726066
Cancer Res. 2010 Aug 1;70(15):6303-12
pubmed: 20647323
Curr Oncol. 2007 Oct;14(5):189-94
pubmed: 17938702
J Biol Chem. 2001 Jun 15;276(24):20809-12
pubmed: 11320076
Neuro Oncol. 2018 Sep 3;20(10):1321-1330
pubmed: 29897522
Cancer Cell. 2017 Mar 13;31(3):326-341
pubmed: 28292436
J Control Release. 2012 Jun 10;160(2):388-93
pubmed: 22019559
Photodiagnosis Photodyn Ther. 2018 Sep;23:190-201
pubmed: 29969678
Nat Med. 2013 Oct;19(10):1264-72
pubmed: 24056773
Oncoimmunology. 2015 Apr 02;4(3):e983961
pubmed: 25949898
J Pharm Sci. 2018 Mar;107(3):922-933
pubmed: 29162424
Neuro Oncol. 2011 Jun;13(6):591-9
pubmed: 21636707
J Neurooncol. 2015 Aug;124(1):13-22
pubmed: 25981803
J Control Release. 2017 Dec 10;267:144-153
pubmed: 28887134
Nanomedicine (Lond). 2018 Aug;13(16):1999-2013
pubmed: 30204064
Cell Adh Migr. 2015;9(1-2):141-53
pubmed: 25569113
J Biomed Nanotechnol. 2019 Jul 1;15(7):1468-1481
pubmed: 31196351
Exp Cell Res. 1992 Nov;203(1):80-90
pubmed: 1426053
J Clin Oncol. 2017 Jul 20;35(21):2402-2409
pubmed: 28640706
CA Cancer J Clin. 2021 Sep;71(5):381-406
pubmed: 34427324
Adv Healthc Mater. 2015 Dec 9;4(17):2719-26
pubmed: 26498165
Drug Deliv. 2017 Nov;24(1):1401-1409
pubmed: 28933201
J Neurooncol. 2014 Mar;117(1):183-189
pubmed: 24519516
Neuro Oncol. 2003 Apr;5(2):79-88
pubmed: 12672279
Cancer Res. 2007 May 1;67(9):4010-5
pubmed: 17483311
Crit Rev Oncog. 2014;19(5):327-36
pubmed: 25404148
Proc Natl Acad Sci U S A. 2019 Jan 15;116(3):997-1006
pubmed: 30602457
Neuromolecular Med. 2015 Dec;17(4):335-52
pubmed: 26224516
J Control Release. 2019 Sep 10;309:72-81
pubmed: 31306678
Cancer Res. 2016 Oct 1;76(19):5671-5682
pubmed: 27530322
Adv Drug Deliv Rev. 2013 Jan;65(1):10-6
pubmed: 23246762
Cancer Res. 2006 Aug 15;66(16):7843-8
pubmed: 16912155
Nat Rev Cancer. 2020 Jan;20(1):26-41
pubmed: 31601988
Br J Surg. 1994 Nov;81(11):1576-90
pubmed: 7827878
J Funct Biomater. 2018 Jan 24;9(1):
pubmed: 29364833
Neurosurgery. 2001 Aug;49(2):380-9; discussion 390
pubmed: 11504114
Expert Rev Med Devices. 2011 Sep;8(5):607-26
pubmed: 22026626
Ther Clin Risk Manag. 2007 Oct;3(5):707-15
pubmed: 18472995
Anticancer Res. 2010 Apr;30(4):1057-64
pubmed: 20530409
JAMA. 2015 Dec 15;314(23):2535-43
pubmed: 26670971
World Neurosurg. 2017 Jul;103:733-740
pubmed: 28434963
Nanoscale. 2017 Aug 3;9(30):10919-10932
pubmed: 28731079
Blood Coagul Fibrinolysis. 1996 Jul;7(5):536-48
pubmed: 8874864
Cell. 2016 Dec 1;167(6):1540-1554.e12
pubmed: 27912061
Cancer Res. 2006 Oct 1;66(19):9535-42
pubmed: 17018610
Sci Rep. 2019 Jul 31;9(1):11085
pubmed: 31366997
Neuro Oncol. 2014 Oct;16(10):1304-12
pubmed: 24723564
J Neurosurg. 2009 Mar;110(3):583-8
pubmed: 19046047
J Neurosurg. 1991 Mar;74(3):441-6
pubmed: 1993909
J Control Release. 2017 Dec 28;268:128-146
pubmed: 29051064
Nanomedicine (Lond). 2014 May;9(6):839-49
pubmed: 24433240
Oncotarget. 2015 Apr 20;6(11):8788-806
pubmed: 25871395
Acta Biomater. 2017 Jan 15;48:319-340
pubmed: 27989920
J Control Release. 2017 Nov 28;266:140-155
pubmed: 28951319
Cancer Res. 1998 Feb 15;58(4):672-84
pubmed: 9485020
Int J Nanomedicine. 2015 Sep 24;10:5995-6008
pubmed: 26451106
J Med Life. 2009 Oct-Dec;2(4):386-93
pubmed: 20108752
Am J Transl Res. 2013 Sep 25;5(6):563-81
pubmed: 24093054
J Control Release. 2021 Sep 10;337:296-305
pubmed: 34298055
JCI Insight. 2018 Nov 2;3(21):
pubmed: 30385717
J Cell Sci. 2001 Jul;114(Pt 14):2553-60
pubmed: 11683383
J Exp Clin Cancer Res. 2008 Dec 24;27:85
pubmed: 19108713
Int J Cancer. 2008 Feb 15;122(4):761-8
pubmed: 17955491
Neoplasia. 2004 Jul-Aug;6(4):343-53
pubmed: 15256056
Cell Adh Migr. 2015;9(1-2):131-40
pubmed: 25695402
J Neurosurg. 1992 Apr;76(4):640-7
pubmed: 1545259
Neuro Oncol. 2021 Aug 2;23(8):1231-1251
pubmed: 34185076
Biomaterials. 2011 Apr;32(12):3340-50
pubmed: 21296415
Lab Invest. 1992 Mar;66(3):303-13
pubmed: 1538585
Biomaterials. 2014 Mar;35(9):2961-70
pubmed: 24393265
FEBS J. 2011 May;278(9):1429-43
pubmed: 21362138
Pharmaceutics. 2018 Oct 09;10(4):
pubmed: 30304861
J Neurooncol. 2018 Jan;136(2):273-280
pubmed: 29139095
Mol Imaging Biol. 2014 Oct;16(5):680-9
pubmed: 24696184
Mol Cancer. 2006 Dec 02;5:67
pubmed: 17140455
Biomaterials. 2012 Jun;33(19):4836-42
pubmed: 22483245
Cancer Microenviron. 2012 Aug;5(2):133-49
pubmed: 21948460
JAMA. 2017 Dec 19;318(23):2306-2316
pubmed: 29260225
Biomaterials. 2016 Sep;101:60-75
pubmed: 27267628
J Control Release. 2016 Dec 28;244(Pt A):14-23
pubmed: 27825958
J Control Release. 2017 Oct 28;264:45-54
pubmed: 28830791
PLoS One. 2014 Jul 29;9(7):e103736
pubmed: 25072631
Clin Pharmacokinet. 2002;41(6):403-19
pubmed: 12074689
J Neurosurg. 1978 Sep;49(3):333-43
pubmed: 355604
Oncogene. 2018 Mar;37(12):1561-1575
pubmed: 29321659
Cancer Res. 2004 Oct 1;64(19):7011-21
pubmed: 15466194
J Clin Neurosci. 2017 Nov;45:288-292
pubmed: 28867360
Neurosurg Clin N Am. 2010 Jan;21(1):159-66
pubmed: 19944974
Cancer Res. 1994 Aug 1;54(15):3988-92
pubmed: 7518347
Crit Rev Oncol Hematol. 2017 Mar;111:60-65
pubmed: 28259296
J Neuropathol Exp Neurol. 1992 Jan;51(1):84-90
pubmed: 1311022
Lancet. 1995 Apr 22;345(8956):1008-12
pubmed: 7723496
Neuro Oncol. 2008 Jun;10(3):254-64
pubmed: 18359864
J Drug Deliv. 2013;2013:860780
pubmed: 23533773
Cancer Res. 1988 Apr 15;48(8):2231-8
pubmed: 3258189
Int J Pharm. 2018 Sep 5;548(1):522-529
pubmed: 30017818
ACS Nano. 2016 Feb 23;10(2):2509-20
pubmed: 26745323
Int J Cancer. 1994 Jan 2;56(1):72-7
pubmed: 8262681
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Neuro Oncol. 2017 Jun 1;19(6):796-807
pubmed: 28115578
Cancer Res. 1993 Oct 15;53(20):4754-6
pubmed: 7691404
Gels. 2017 Jan 24;3(1):
pubmed: 30920503
Cancer Res. 2006 Dec 15;66(24):11771-80
pubmed: 17178873
Nat Commun. 2017 Dec 4;8(1):1913
pubmed: 29203859
Biomaterials. 2013 Jan;34(4):1135-45
pubmed: 23146434